Aktis Oncology, Inc. - Common stock (NQ:AKTS)
Price and Volume
Detailed Quote| Volume | 202,712 |
| Open | 23.05 |
| Bid (Size) | 20.96 (200) |
| Ask (Size) | 21.42 (200) |
| Prev. Close | 21.75 |
| Today's Range | 20.25 - 23.50 |
| 52wk Range | 19.33 - 29.16 |
| Shares Outstanding | 51,310,014 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Crude Oil Down 1%; Webuy Global Shares Spike Higher ↗
December 16, 2024
12 Information Technology Stocks Moving In Monday's Pre-Market Session ↗
November 25, 2024
12 Information Technology Stocks Moving In Friday's Pre-Market Session ↗
November 22, 2024
Why Akoustis Technologies Stock Is Up Today ↗
August 13, 2024
Akoustis Announces Leadership Transition
August 08, 2024
Frequently Asked Questions
Is Aktis Oncology, Inc. - Common stock publicly traded?
Yes, Aktis Oncology, Inc. - Common stock is publicly traded.
What exchange does Aktis Oncology, Inc. - Common stock trade on?
Aktis Oncology, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aktis Oncology, Inc. - Common stock?
The ticker symbol for Aktis Oncology, Inc. - Common stock is AKTS on the Nasdaq Stock Market
What is the current price of Aktis Oncology, Inc. - Common stock?
The current price of Aktis Oncology, Inc. - Common stock is 21.24
When was Aktis Oncology, Inc. - Common stock last traded?
The last trade of Aktis Oncology, Inc. - Common stock was at 01/13/26 01:49 PM ET
What is the market capitalization of Aktis Oncology, Inc. - Common stock?
The market capitalization of Aktis Oncology, Inc. - Common stock is 1.09B
How many shares of Aktis Oncology, Inc. - Common stock are outstanding?
Aktis Oncology, Inc. - Common stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.